Cargando…

Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease

Activator protein 1 (AP-1) (Fos/Jun) is a transcriptional regulator composed of members of the Fos and Jun families of DNA binding proteins. The functions of AP-1 were initially studied in mouse development as well as in the whole organism through conventional transgenic approaches, but also by gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Zenz, Rainer, Eferl, Robert, Scheinecker, Clemens, Redlich, Kurt, Smolen, Josef, Schonthaler, Helia B, Kenner, Lukas, Tschachler, Erwin, Wagner, Erwin F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374460/
https://www.ncbi.nlm.nih.gov/pubmed/18226189
http://dx.doi.org/10.1186/ar2338
_version_ 1782154458937950208
author Zenz, Rainer
Eferl, Robert
Scheinecker, Clemens
Redlich, Kurt
Smolen, Josef
Schonthaler, Helia B
Kenner, Lukas
Tschachler, Erwin
Wagner, Erwin F
author_facet Zenz, Rainer
Eferl, Robert
Scheinecker, Clemens
Redlich, Kurt
Smolen, Josef
Schonthaler, Helia B
Kenner, Lukas
Tschachler, Erwin
Wagner, Erwin F
author_sort Zenz, Rainer
collection PubMed
description Activator protein 1 (AP-1) (Fos/Jun) is a transcriptional regulator composed of members of the Fos and Jun families of DNA binding proteins. The functions of AP-1 were initially studied in mouse development as well as in the whole organism through conventional transgenic approaches, but also by gene targeting using knockout strategies. The importance of AP-1 proteins in disease pathways including the inflammatory response became fully apparent through conditional mutagenesis in mice, in particular when employing gene inactivation in a tissue-specific and inducible fashion. Besides the well-documented roles of Fos and Jun proteins in oncogenesis, where these genes can function both as tumor promoters or tumor suppressors, AP-1 proteins are being recognized as regulators of bone and immune cells, a research area termed osteoimmunology. In the present article, we review recent data regarding the functions of AP-1 as a regulator of cytokine expression and an important modulator in inflammatory diseases such as rheumatoid arthritis, psoriasis and psoriatic arthritis. These new data provide a better molecular understanding of disease pathways and should pave the road for the discovery of new targets for therapeutic applications.
format Text
id pubmed-2374460
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23744602008-05-09 Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease Zenz, Rainer Eferl, Robert Scheinecker, Clemens Redlich, Kurt Smolen, Josef Schonthaler, Helia B Kenner, Lukas Tschachler, Erwin Wagner, Erwin F Arthritis Res Ther Review Activator protein 1 (AP-1) (Fos/Jun) is a transcriptional regulator composed of members of the Fos and Jun families of DNA binding proteins. The functions of AP-1 were initially studied in mouse development as well as in the whole organism through conventional transgenic approaches, but also by gene targeting using knockout strategies. The importance of AP-1 proteins in disease pathways including the inflammatory response became fully apparent through conditional mutagenesis in mice, in particular when employing gene inactivation in a tissue-specific and inducible fashion. Besides the well-documented roles of Fos and Jun proteins in oncogenesis, where these genes can function both as tumor promoters or tumor suppressors, AP-1 proteins are being recognized as regulators of bone and immune cells, a research area termed osteoimmunology. In the present article, we review recent data regarding the functions of AP-1 as a regulator of cytokine expression and an important modulator in inflammatory diseases such as rheumatoid arthritis, psoriasis and psoriatic arthritis. These new data provide a better molecular understanding of disease pathways and should pave the road for the discovery of new targets for therapeutic applications. BioMed Central 2008 2008-01-18 /pmc/articles/PMC2374460/ /pubmed/18226189 http://dx.doi.org/10.1186/ar2338 Text en Copyright © 2008 BioMed Central Ltd
spellingShingle Review
Zenz, Rainer
Eferl, Robert
Scheinecker, Clemens
Redlich, Kurt
Smolen, Josef
Schonthaler, Helia B
Kenner, Lukas
Tschachler, Erwin
Wagner, Erwin F
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
title Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
title_full Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
title_fullStr Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
title_full_unstemmed Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
title_short Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
title_sort activator protein 1 (fos/jun) functions in inflammatory bone and skin disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374460/
https://www.ncbi.nlm.nih.gov/pubmed/18226189
http://dx.doi.org/10.1186/ar2338
work_keys_str_mv AT zenzrainer activatorprotein1fosjunfunctionsininflammatoryboneandskindisease
AT eferlrobert activatorprotein1fosjunfunctionsininflammatoryboneandskindisease
AT scheineckerclemens activatorprotein1fosjunfunctionsininflammatoryboneandskindisease
AT redlichkurt activatorprotein1fosjunfunctionsininflammatoryboneandskindisease
AT smolenjosef activatorprotein1fosjunfunctionsininflammatoryboneandskindisease
AT schonthalerheliab activatorprotein1fosjunfunctionsininflammatoryboneandskindisease
AT kennerlukas activatorprotein1fosjunfunctionsininflammatoryboneandskindisease
AT tschachlererwin activatorprotein1fosjunfunctionsininflammatoryboneandskindisease
AT wagnererwinf activatorprotein1fosjunfunctionsininflammatoryboneandskindisease